Milea Timbergen

262 19 . Gundy CM, Fayers PM, Groenvold M, Petersen MA, Scott NW, Sprangers MA, et al. Comparing higher order models for the EORTC QLQ-C30. Qual Life Res. 2012;21(9):1607-1617. 20 . Benjamin K, Vernon MK, Patrick DL, Perfetto E, Nestler-Parr S, Burke L. Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report. Value Health. 2017;20(7):838-855. 21 . Slade A, Isa F, Kyte D, Pankhurst T, Kerecuk L, Ferguson J, et al. Patient reported outcome measures in rare diseases: a narrative review. Orphanet J Rare Dis. 2018;13(1):61. 22 . Stefaner M, Rasuch F, Leist J, Paeschke M, Baur D, Kekeritz T. OECD Better Life Index, Netherlands: The Organisation for Economic Co-operation and Development; 2017 Available from: http://www.oecdbetterlifeindex.org/countries/netherlands/. 23 . Rolstad S, Adler J, Ryden A. Response burden and questionnaire length: is shorter better? A review and meta-analysis. Value Health. 2011;14(8):1101-1108. 24 . Gounder MM, Maddux L, Paty J, Atkinson TM. Prospective development of a patient-reported outcomes instrument for desmoid tumors or aggressive fibromatosis. Cancer. 2019;126(3):531-539. 25 . SpringWorks Therapeutics, Inc. NCT03785964 - Nirogacestat for Adults With Desmoid Tumor/ Aggressive Fibromatosis (DT/AF) (DeFi) Available from: https://clinicaltrials.gov/ct2/show/NCT03785964?term=03785964&draw=2&rank=1. 26 . Iterion Therapeutics NCT03459469 - Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059 2018. Available from: https://clinicaltrials.gov/ct2/show/NCT03459469?term=NCT03459469&draw=2&rank=1. 27 . Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol. 2016;34(6):557-565. 28 . Jensen RE, Rothrock NE, DeWitt EM, Spiegel B, Tucker CA, Crane HM, et al. The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care. Med Care. 2015;53(2):153-159. 29 . Luckett T, Butow PN, King MT. Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psychooncology. 2009;18(11):1129-1138. 30 . Feldman-Stewart D, Brundage MD. A conceptual framework for patient-provider communication: a tool in the PRO research tool box. Qual Life Res. 2009;18(1):109-114. 31 . Snyder CF, Aaronson NK. Use of patient-reported outcomes in clinical practice. Lancet. 2009;374(9687):369-370. 9